Eriko Takano
Papers
4
Total Citations
142
H-Index
4
About
Eriko Takano is a pioneering researcher at the intersection of synthetic biology, metabolic engineering, and automated biomanufacturing. Her work focuses on harnessing microbial systems to produce high-value natural products, with particular emphasis on polyketides and terpenoids — compound classes that underpin many of medicine's most critical antimicrobial and anticancer drugs, including erythromycin and doxorubicin. Takano's most celebrated contribution involves developing "plug-and-play" biosynthetic platforms in *Escherichia coli* for the combinatorial production of aromatic polyketides, offering a promising strategy to replenish dwindling drug pipelines (53 citations). Complementing this, her work on monoterpene synthase screening through automated pipelines has opened scalable routes to pharmaceuticals, fragrances, and biofuels (37 citations). She has also been instrumental in advancing next-generation smart biomanufacturing, integrating machine learning with the Design-Build-Test-Learn (DBTL) cycle to accelerate bio-based compound development — work closely associated with the SYNBIOCHEM Centre at the University of Manchester (38 citations). Her contributions to automated DNA assembly further streamline the construction of complex biosynthetic pathways. Collectively, Takano's research is reshaping how the scientific community engineers biology for sustainable, industrially relevant chemical production.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4